Makani Science

Better Breathing, Better Health

Claim My Business
Security Type
Common Stock
Min Investment
Offering Date
December 30, 2022
Expected Close Date
March 30, 2023
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

After you stop breathing, it only takes 4 minutes for permanent brain damage to start. Surprisingly, this critical vital sign is poorly monitored, using bulky, wired systems based on technology conceived half a century ago. Makani Science’s novel, compact, and wireless system is poised to bring breathing monitoring to new heights, making this neglected vital sign easier to measure, and unlocking a multi-billion-dollar market. We are currently pre-revenue, pre-FDA clearance and our product is in pre-production.

Key Deal Facts

The Makani Science Respiration Monitor uses a completely novel sensor technology, unlike current monitors, and has the potential to become the new standard of care for this vital sign.

Our unique sensor has the potential to make breathing monitoring more accessible in many different wearable applications, tapping into lucrative multi-billion dollar markets increasing at a CAGR of 18.5% fueled by the rise of telehealth.*

Clinicians, potential strategic partners, and researchers have already expressed interest in our product and are excited by our technology and how it can improve the state of the industry.

Management Team / Advisory Board Bios

Michael ChuCo-Founder and CEOMichael is one of the original founders of Makani Science. He completed his PhD at the University of California, Irvine, in Biomedical Engineering, where he co-authored over 10 peer-reviewed publications and is listed as an inventor on 3 patents. His research around wearable respiratory monitoring has been highlighted in various news and media outlets and serves as the foundational technology for Makani Science.
Michael has worked closely with the Makani Science team from day one to develop the Makani Science Respiratory Monitoring System. He has also actively participated in the business development side of the company, establishing partnerships for future collaborations and research opportunities.
Michael participated in Y-Combinator and MedTech Innovator as part of their 2021 summer cohort where he helped raised additional funding for the company. In Q4 of 2021, Michael was selected as the full time CEO for Makani Science., Ray ChanBoard ChairmanRay Chan is a prominent investor who has been recognized as one of Orange County Business Journal’s most influential business leaders since 2017. Ray is the Managing Director of K5 Ventures and has been leading county-wide efforts to build the tech and startup ecosystem within Orange County. He is also an active member of Tech Coast Angels and an Investment Partner for their Angel Capital Entrepreneur Funds.
Ray has a 30+ year track record of successful business execution and of being a startup queen/kingmaker. Ray has personally made over 300 investments and is well-known for rewarding shareholders with exceptional financial returns.
 As the co-founder of Koa Accel and Managing Director of the Koa Accel Venture Fund, Ray is excited to combine all of his expertise and passions to transform life-saving MedTech ideas into thriving commercial ventures.
Greg BuchertBoard DirectorGreg Buchert, MD, MPH is the CEO of GSB Health Management Solutions, a consulting firm focused on innovative solutions to improve the health care delivery system. He has over 25 years of C-Suite experience in health plan leadership roles and leverages that in his roles as advisor to startup companies. He is the former President and CEO of Blue Shield of California’s Promise Health Plan that serves over 500,000 Medicaid, Medicare and Dual Eligible members. He previously served as the Chief Executive Officer that launched Centene’s first Medicaid Managed Care Plan in California and later as Chief Medical Officer of HealthNet after its acquisition by Centene. 
Greg was a founding executive for CalOptima, a public managed care organization where he served as Chief Operating Officer and Medical Director. He began his professional career as a pioneer in Pediatric Emergency Medicine. His previous positions include work as a Principal Consultant with Health Management Associates, a national healthcare consulting firm. Greg started his career as a Pediatric Emergency Physician serving in leadership positions at two children’s hospitals and as administrative director of a medical group. 
He is a Fellow of the American College of Emergency Physicians and American Academy of Pediatrics. Greg has a passion for innovation, the expanded use of technology in healthcare, improving quality of care and heath equity.
Stephen YoungCFO (Chief Financial Officer)Stephen has 25 years of extensive experience in financial operations management in the consumer packaged goods industry.
He has successfully built and led finance teams with Del Monte Foods and Safeway, Inc. His passion for building financial operations from the ground up has led him from his recent start-up experiences to KOA ACCEL. Stephen’s expertise in economic analysis, strategic planning, and financial modeling has been instrumental to the successful launches of various new products domestically and internationally. He is also highly skilled in developing business processes, systems, and building financial/accounting infrastructure.
Stephen received his MBA degree from Southern Illinois University and both his B.S. degrees in Finance and Marketing from the University of Illinois at Urbana-Champaign
Arlene BumbHead of MarketingArlene is a senior executive with over 30 years of experience in medical/healthcare marketing, business development, and management. Her areas of expertise include new product development and commercial launch (US and OUS); strategic and tactical marketing, market research, and product management; and, external communications.
She has played an integral part in the growth of large established companies, such as Pfizer (Shiley), Medtronic, Beckman-Coulter, St. Jude Medical, Thermo-Fischer, and most recently Arlene has focused on building the identity, value and infrastructure of many start-ups including EP Dynamics, Reviticell, Pegasus Biologics, PhageTech, BioMedGPS, and TinyKicks. Her consulting company, Silvergleid and Associates, has performed market due diligence for IPOs and advised international companies on the suitability for US market entry.
Arlene holds a BS in Chemistry and Biology from Simmons College and MBA courses from Boston University.
Stephane GobronHead of EngineeringStephane completed his Master of Plastic Engineering in France (INSA Strasbourg) before completing a second Master of Science in Chemical Engineering at Syracuse University (NY). To follow his interest in inventing new designs and products, he chose to work in the medical device industry, focusing on R&D and new product development. He is a highly accomplished medical device designer, with 31 device patents to his name spanning several medical fields of application: monitoring, ophthalmology, cardiology, implants, and minimally invasive endoscopic surgeries. 
Stephane has been working in the medical device Industry for over 25 years; he started in large cap , high-volume corporations (Boston Scientific, Novartis) to gradually focus onto the start-up world and develop his entrepreneurial business sense. He held various technical positions of increasing responsibilities and oversaw the development of several devices from concept definition to FDA clearance and market launch. He transitioned into executive management almost 15 years ago: leading technical teams, interacting with agencies, and helping with Venture Capital fund raising. 
Michelle KhineScientific Co-Founder & DirectorMichelle Khine, Ph.D. is a Professor of Biomedical Engineering at UC Irvine. She is the founding Director of Faculty Innovation at the Samueli School of Engineering and founding Director of BioENGINE (BioEngineering Innovation and Entrepreneurship) at UC Irvine. Prior to joining UC Irvine in 2009, she was an Assistant & Founding Professor at UC Merced. Michelle received her BS and MS from UC Berkeley in Mechanical Engineering and her PhD in Bioengineering from UC Berkeley and UCSF. She is the Scientific Founder of 6 start-up companies. Michelle was the recipient of the TR35 Award and named one of Forbes ’10 Revolutionaries’ in 2009 and by Fast Company Magazine as one of the ‘100 Most Creative People in Business’ in 2011. She was awarded the NIH New Innovator’s Award, was named a finalist in the World Technology Awards for Materials, and was named by Marie‐Claire magazine as ‘Women on Top: Top Scientist’. She was named Innovator of the Year 2017 for the Samueli School of Engineering at UC Irvine. Michelle is a Fellow of AIMBE (American Institute of Medical and Biological Engineering, recognizing the top 2% of biomedical engineers nationally) and well as a Fellow of the National Academy of Inventors.
Anas DeiraniehEngineerAnas received his B.S. degree in Biomedical Engineering from the University of California, Irvine. During his time at the University, he did research in Dr. Michelle Khine’s lab and developed a strong foundation in fabricating soft wearable electronics. After graduating, Anas joined Makani Science, where he spearheaded the protocol development and fabrication of the novel sensors used by the company. Anas also plays an instrumental role in the verification and validation testing of the Makani Science Respiratory Monitoring System.
Gracie ChanOperations CoordinatorGracie studied Business Management and Human Resources at Cal Poly Pomona. She is passionate about sustainability and social responsibility. While a student, she learned business management through various internships and campus involvements. She supports Makani Science by coordinating projects and programs. Gracie aids the team with resource, meeting, and information coordination. In addition, she helps oversee administrative and scheduling tasks.
Amount Raised : $69,021
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter